François Céline, Fares Mourad, Baiocchi Claudio, Maixent Jean Michel
INSERM U927, Faculty of Medicine, University of Poitiers & CHU la Miléterie, Poitiers, France.
Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
J Intercult Ethnopharmacol. 2015 Jan-Mar;4(1):1-5. doi: 10.5455/jice.20141013041312. Epub 2014 Nov 28.
The increased consumption of traditional medicinal plants has been driven by the notion that herbal products are safe and efficient. The purpose of this study was to evaluate the safety and the protective effect of a hydro alcoholic extract of Desmodium adscendens (DA) on liver (HEPG2) and kidney (LLC-PK1) cells.
A hydro alcoholic extract of DA was used. HEPG2 or LLC-PK1 cells were treated with different does of DA, and viability test (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium [MTS]), cytotoxicity assay lactate dehydrogenase (LDH release) and study of the cell morphology were used in order to determine effects of DA on these two cells.
A viability test (MTS), a cytotoxicity assay LDH release and a study of the cell morphology revealed that pretreatment with 1 mg/ml or 10 mg/ml DA did not alter viability or LDH release in HEPG2 or LLC-PK1 cells. However, DA at the dose of 100 mg/ml significantly decreased cell viability, by about 40% (P < 0.05). Further, MTS studies revealed that DA 1 mg/ml or 10 mg/ml protected LLC-PK1 cells against a glucose-induced oxidative stress of 24 h (P < 0.05).
Hence, the lowest concentrations of DA (1 mg/ml and 10 mg/ml) were safe for HEPG2 and LLC-PK1 and protective against an oxidative stress in LLC-PK1 cells. These data suggest that DA extracts used as a traditional herbal as food health supplements should be used at the lowest dosage.
传统药用植物消费的增加是由草药产品安全且有效的观念推动的。本研究的目的是评估升马唐水醇提取物(DA)对肝脏(HEPG2)和肾脏(LLC-PK1)细胞的安全性及保护作用。
使用DA的水醇提取物。用不同剂量的DA处理HEPG2或LLC-PK1细胞,并采用活力测试(3-(4,5-二甲基噻唑-2-基)-5-(3-羧甲氧基苯基)-2-(4-磺基苯基)-2H-四唑[MTS])、细胞毒性测定(乳酸脱氢酶[LDH]释放)及细胞形态学研究来确定DA对这两种细胞的影响。
活力测试(MTS)、细胞毒性测定(LDH释放)及细胞形态学研究表明,用1mg/ml或10mg/ml DA预处理不会改变HEPG2或LLC-PK1细胞的活力或LDH释放。然而,100mg/ml剂量的DA显著降低细胞活力,降低约40%(P<0.05)。此外,MTS研究表明,1mg/ml或10mg/ml的DA可保护LLC-PK1细胞免受24小时葡萄糖诱导的氧化应激(P<0.05)。
因此,最低浓度的DA(1mg/ml和10mg/ml)对HEPG2和LLC-PK1细胞是安全的,且对LLC-PK1细胞的氧化应激具有保护作用。这些数据表明,用作传统草药食品健康补充剂的DA提取物应以最低剂量使用。